Microbiology 2019 | Madrid Spain...

Researchers have discovered one of the first concrete examples of how the microbiome can interfere with a drug's intended path through the body. Focusing on levodopa (L-dopa), the primary treatment for Parkinson's disease, they identified which bacteria out of the trillions of species is responsible for degrading the drug and how to stop this microbial interference.

For more details: https://microbiology.cmesociety.com/conference-brochure

#bacteriology #virology #diseases #diagnosis #microbiology #conference